July 23, 2014 1:19 PM ET

Healthcare Equipment and Supplies

Company Overview of CareDx, Inc

Company Overview

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA ...

3260 Bayshore Boulevard

Brisbane, CA 94005

United States

Founded in 1998

55 Employees

Phone:

415-287-2300

Fax:

415-287-2450

Key Executives for CareDx, Inc

Chief Executive Officer
Age: 47
Total Annual Compensation: $350.0K
Chief Medical Officer and Executive Vice President
Age: 65
Total Annual Compensation: $365.7K
Chief Compliance Officer and Chief Business Officer
Age: 44
Total Annual Compensation: $308.3K
Compensation as of Fiscal Year 2013.

CareDx, Inc Key Developments

CareDx, Inc(NasdaqGM:CDNA) added to NASDAQ Composite Index

CareDx, Inc will be added to the NASDAQ Composite Index.

CareDx Seeks Acquisitions

CareDx, Inc. has filed an IPO in the amount of $50 million. CareDx intends to use the net proceeds from offering for research and development, including research aimed at expanding the clinical utility of AlloMap and the development of new solutions for the surveillance of heart and kidney transplant recipients, for sales and marketing activities, including expansion of our sales force to support the ongoing commercialization of our products and remainder for general and administrative expenses (including personnel related costs and the costs of operating as a public company), and for working capital and other general corporate purposes. CareDx may also use a portion of the net proceeds from this offering for the acquisition of, or investment in, technologies, solutions or businesses that complement our business.

XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM

XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM. Venue: The Waldorf-Astoria Hotel, Conrad Room, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Fenwal Inc. United States
Pharmaworks Inc. United States
STARR Life Sciences Corp. United States
U.S. Biopsy LLC United States
CJPS Healthcare Supplies and Equipment, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 21, 2014
ImmuMetrix, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CareDx, Inc, please visit www.xdx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.